Thiazolidinedione, also known as peroxisome proliferator-activated receptor-gamma (PPARg) agonists, have been clinically introduced as oral antidiabetics in type 2 diabetes mellitus [1]. The gene discussed is PPARG; the disease is type 2 diabetes mellitus.